Gilead Sciences (GILD) EPS (Diluted) (2009 - 2026)
Gilead Sciences' EPS (Diluted) was -$8.44 in Q2 2026, compared with $1.56 a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) EPS (Diluted) (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gilead Sciences' EPS (Diluted) was -$2.61 through Jun 30, 2026; for FY2025, it was $6.78.
- EPS (Diluted) shows a five-year compound annual growth rate of 133.6% (FY2020 to FY2025).
- In earlier years, EPS (Diluted) was $0.38 in FY2024 (-91.5%), $4.50 in FY2023 (+23.8%), $3.64 in FY2022 (-26.2%) and $4.93 in FY2021.
- The Q2 2026 figure marks the lowest quarterly EPS (Diluted) in data going back to Q1 2009.
- Compared with a year earlier, EPS (Diluted) was higher in five of the last six quarters, with growth averaging 37.3%.
- The best year-over-year quarter for EPS (Diluted) over five years was Q3 2021 (growth of 619.4%); the worst was Q1 2022 (a decline of 98.9%).
- Per Business Quant data, GILD's EPS (Diluted) in the three quarters before Q2 2026 was $1.61 (Q1 2026), $1.74 (Q4 2025) and $2.43 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 4.31 |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 1.62 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.44 |
| Mar 31, 2026 | 1.61 |
| Dec 31, 2025 | 1.74 |
| Sep 30, 2025 | 2.43 |
| Jun 30, 2025 | 1.56 |
| Mar 31, 2025 | 1.04 |
| Dec 31, 2024 | 1.42 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | 1.29 |
| Mar 31, 2024 | -3.34 |
| Dec 31, 2023 | 1.14 |
| Sep 30, 2023 | 1.73 |
| Jun 30, 2023 | 0.83 |
| Mar 31, 2023 | 0.80 |
| Dec 31, 2022 | 1.30 |
| Sep 30, 2022 | 1.42 |
| Jun 30, 2022 | 0.91 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | 2.05 |
API Access
Gilead Sciences EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();